Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Vaessen

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Transplantation Proceedings|September 18, 1997
Nonspecific immune reactivity of peripheral blood mononuclear cells is related to graft vascular diseaseN M van Besouw, C R Daane, L M Vaessen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 12, 2000
Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipientsF B Oei, M J Welters, C J Knoop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1991
Phenotypic and functional analysis of T cell receptor gamma delta-bearing cells isolated from human heart allograftsL M Vaessen, A J Ouwehand, C C Baan, et al.
Transplantation Proceedings|February 1, 1995
The effect of antithymocyte globulin therapy on frequency and avidity of allospecific committed CTL in clinical heart transplantsC C Baan, L M Vaessen, E H Loonen, et al.
Transplantation Proceedings|February 1, 1995
Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipientsT van Gelder, C J Knoop, C J Hesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat modelF B Oei, M J Welters, L M Vaessen, et al.
Transplantation|February 1, 1993
Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 splitC C Baan, L M Vaessen, F ten Kate, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|September 18, 1997
Nonspecific immune reactivity of peripheral blood mononuclear cells is related to graft vascular diseaseN M van Besouw, C R Daane, L M Vaessen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 12, 2000
Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipientsF B Oei, M J Welters, C J Knoop, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1991
Phenotypic and functional analysis of T cell receptor gamma delta-bearing cells isolated from human heart allograftsL M Vaessen, A J Ouwehand, C C Baan, et al.
Transplantation Proceedings|February 1, 1995
The effect of antithymocyte globulin therapy on frequency and avidity of allospecific committed CTL in clinical heart transplantsC C Baan, L M Vaessen, E H Loonen, et al.
Transplantation Proceedings|February 1, 1995
Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipientsT van Gelder, C J Knoop, C J Hesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 1997
The avidity, not the mere presence, of primed cytotoxic T-lymphocytes for donor human leukocyte class II antigens determines their clinical relevance after heart transplantationN E van Emmerik, E H Loonen, L M Vaessen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathwaysN M van Besouw, L M Vaessen, C J Knoop, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat modelF B Oei, M J Welters, L M Vaessen, et al.
Transplantation|February 1, 1993
Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 splitC C Baan, L M Vaessen, F ten Kate, et al.
Transplantation|July 29, 1998
C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejectionN E van Emmerik, C J Knoop, L M Vaessen, et al.
Pageof 9